6-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of October, 2023

COMMISSION FILE NUMBER 001-38455

MorphoSys AG

Semmelweisstrasse 7

82152 Planegg

Germany

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F: Form 20-F x Form 40-F ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨

On October 9, 2023, MorphoSys AG (the “Company”) published a notification of managers transactions from Krisja Vermelyen.

Exhibits

99.1    Notification of managers`transactions according to article 19 MAR

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

MORPHOSYS AG (Registrant)

Date: October 10, 2023    By:    /s/ i.A. Isabelle Degbegni

        Name: Isabelle Degbegni

        Title:    Director Investor Relations

    By:    /s/ i.A. Dr. Robert Mayer

        Name: Dr. Robert Mayer

        Title:    Director Investor Relations     

EX-99.1

Notification of managers`transactions according to article 19 MAR

Via Fax to BaFin (+49(0)228/4108-62963) and to the issuer

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Krisja Vermeylen
2	Reason for the notification
a)	Position/status	Member of the Supervisory Board of MorphoSys AG
b)	Initial notification/Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	MorphoSys AG
b)	LEI	529900493806K77LRE72
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument. type of instrument Identification code	Shares of MorphoSys AG, ISIN DE0006632003
b)	Nature of the transaction	Acquisition
c)	Price(s) and volume(s)	Price(s)  Volume(s) 23.53 € 23,530.00 €
d)	Aggregated information Aggregated volume Price	23,530.00 € 23.53 €
e)	Date of the transaction	2023-10-06; UTC+2
f)	Place of the transaction	Morgan Stanley Europe S.E. – systematic internaliser

(1)  Commission Delegated Regulation (EU) 2016/522 of 17 December 2015 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council as regards an exemption for certain third countries public bodies and central banks. the indicators of market manipulation. the disclosure thresholds. the competent authority for notifications of delays. the permission for trading during closed periods and types of notifiable managers' transactions (see page 1 of this Official Journal).